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Case report
Non-menstrual associated toxic shock
syndrome
P G Murphy, W Holmes, T S Wilson, J P Alexander
Accepted 17 August 1987.
A 40-year-old female patient developed toxic shock syndrome following breast
surgery. A toxin producing strain ofStaphylococcus aureus was isolated from the
post-operative wound.
INTRODUCTION
The term toxic shock syndrome (TSS) was first used in 1978 1 to describe a
condition characterised bysudden onsetoffever, shock, confusion, subcutaneous
oedema, erythematous rash which desquamates in convalescence, abnormalities
of many other systems, and negative blood culture. These effects are thought to
be due to circulating staphylococcal toxins arising from a focus of staphylococcal
infection. It has most commonly been associated with the use of certain types of
tampons during menstruation, but is now increasingly being recognised in up to
13% of cases in a variety of clinical situations not associated with menstruation.2
Staphylococcus aureus has been associated with TSS and most strains isolated
from patients with this syndrome have produced enterotoxin F or pyrogenic
exotoxin C, now thought to be the same toxin and renamed Toxic Shock
Syndrome Toxin-1 (TSST-1). However, other strains of Staphylococcus aureus
implicated in the syndrome have produced different toxins, particularly entero-
toxins B and C 3 in non-menstrual cases. Mortality is higher in these cases with
non -TSST-1 producing strains than with TSST-1 producing strains.4 We report
here a patient who fulfilled the case definition of the Center for Disease Control,
Atlanta, USA,5 and which we believe is the first case notified in Northern Ireland.6
CASE HISTORY
A 40-year -old woman was admitted to another hospital for removal of a breast
lump. Surgery was uneventful and she was discharged the following day. The
biopsy was subsequently reported as benign fibroadenosis. Two days later the
patient was readmitted with pyrexia (40°C), hypotension (90/40 mmHg), and
an erythematous rash on the trunk which spread rapidly to all limbs over the next
two days. The patient was commenced on benzyl penicillin and gentamicin for a
presumed diagnosis of septicaemia, possibly meningococcal.
Two days after this second admission the patient was transferred to the intensive
care unit of this hospital. The breast wound, although notpainful, exuded a slight
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discharge from which Staphylococcus aureus was cultured and the antibiotic
therapy was changed to flucloxacillin and gentamicin on the advice of the
bacteriologist.
Otherclinicalfeatures includedvomiting, periorbital oedema, pulmonaryoedema,
leg muscle myalgia, confusion, and disorientation in time and place. Laboratory
investigations showed a leucocytosis (20 x 109/1), impaired renal function
(creatinine 395 pmol/l), and impaired hepatic function (bilirubin 64 pmol/l,
aspartate transaminase 184 pmol/l, alanine transaminase 70 pmol/l, and lactate
dehydrogenase 595 pmol/l). There was also an elevated creatinine kinase (1589
pmol/l), a decreased serum calcium (1.68 mmol/l), and an increased serum
phosphate (1.6 mmol/l). The haemoglobin dropped from 12.5 g/dl to 9.2 g/dl
over 48 hours without any signs of blood loss but this may have been contributed
to bya dilutional effect. Acoagulopathy was detected with apartial thromboplastin
time of 72 seconds (control 44s), a fibrinogen degradation products level of 32
pg/ml (normal 0-8) and a low platelet count (105 x 109/1). All these features
are characteristic of TSS.
On the eighth post-operative day the rash had faded considerably and there
had been no pyrexia for 48 hours. However, the creatinine continued to rise
(418 pmol/l) and dopamine was still required to maintain the blood pressure at
100/70 mmHg. The patient was then taken back to theatre for exploration ofthe
breast wound in which considerable necrosis was observed and Staphylococcus
aureus was re-isolated from the wound.
The patient made a gradual recovery over the next few weeks. Desquamation
occurred throughout the area of distribution of the raswh starting two weeks after
the rash had disappeared and continuing for three weeks into convalescence.
This was followed by marked hair and nail loss with subsequent regrowth after
several months. These are the convalescent features characteristic of TSS. The
patient was discharged one month after admission.
BACTERIOLOGY
The strain of Staphylococcus aureus isolated from the wound was non-typable
by phage typing at the routine test dose x 100. It was sensitive to benzyl
penicillin with a minimum inhibitory concentration (MIC) of 0.125 pg/mI
and a minimum bactericidal concentration (MBC) of 0.25 pg/ml, and also to
flucloxacillin (MIC 0.5 pg/mI and MBC 0.5 pg/ml). Screening swabs from
various carriage sites did not produce similar strains of Staphyloccocus aureus.
A viridans group streptococcus was isolated from one of four blood culture
bottles taken on the day of re-admission, but this was not considered clinically
relevant. Staphylococcus aureus was not isolated from blood culture.
Toxin studies are not routinely available but tests carried out at a reference
laboratory showed that this strain of Staphylococcus aureus did not produce
TSST-1, but did produce enterotoxin C. Limited serum antitoxin studies in both
acute and convalescent sera showed the presence of antibody to TSST-1 and to
enterotoxin B but not against enterotoxin A. Unfortunately antibody studies
against enterotoxin C and other toxins were not available in the reference
laboratory.
DISCUSSION
Up to 15% ofsome reported series of non -menstrual TSS have followed surgery,
from which a median incubation period of two days has been estimated.2
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Typically, the wound is not painful nor clinically suspicious of being infected.
Other cases have been described, associated with subcutaneous abscesses,
cellulitis, infected insect bites, hydradenitis suppurativa, an infected cutaneous
ulcer and an infected burn.2
Menstrual and non-menstrual associated TSS strains appear to have different
bacteriological features. In this case, the strain of Staphylococcus aureus
was not phage-typable. Epidemiological studies have shown that strains of
Staphylococcus aureus in menstrual associated TSS are usually in phage
group 1,4 and non-menstrual associated TSS strains are either in other phage
groups or are not phage-typable. Also, this strain did not produce TSST-1 and
did produce enterotoxin C. Although TSST-1 is produced by about 90% of
strains from reported cases of menstrual associated TSS, it is only associated with
about 60% of non -menstrual associated cases, and it has recently been
suggested that its role is not essential in the pathogenesis ofTSS and that other as
yet unrecognised toxins may play a part.4
Antibodies may have a protective role, as 88% of control group patients have
antibody titres to TSST-1,7 whereas only 18% of acute phase sera8 and
20 - 30% of convalescent sera of all TSS patients show antibody to TSST-1.9
Patients with TSS would appear to have a defect in the anti-TSST-1 immune
response as shown by the low percentage of patients who seroconvert. The
antibody titres in these patients are also much lower than those of control sera.3
This may also explain the high recurrence rate of 28% in the same individual
patients.5 Significant antibody titres to TSST-1 are present in normal human
immunoglobulin 10 and this may have a therapeutic role in the future when the
causative toxin has been more clearly identified.
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